Clinical Trials Logo

Clinical Trial Summary

Food allergy is on the rise within the pediatric population. Having a food allergy can cause medical, nutritional and psychological issues in those who suffer with it. Although making the appropriate diagnosis of food allergy is very important, properly diagnosing food allergy has been a challenge. Skin prick testing and food-specific immunoglobulin-e (IgE) testing of the blood can give positive results that are false. Currently, Oral Food Challenges are the best way to diagnose a food allergy. Unfortunately, Oral Food Challenges are time consuming and may not be readily available to suspected food allergy sufferers. This study is designed to examine the effectiveness of an allergy-detecting blood test called ImmunoCAP manufactured by the company, ThermoFisher.

Soybean is one of the eight allergy-inducing foods that are responsible for 90% of all food allergies. A part of the study is to allow the study Sponsor to use some of the blood sample collected from you to test if genetically-changed soy has more or less allergy producing factors. This is important to the Sponsor to test the safety of their genetically modified soy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01950559
Study type Observational
Source University of Colorado, Denver
Contact
Status Terminated
Phase
Start date September 2013
Completion date May 15, 2018

See also
  Status Clinical Trial Phase
Completed NCT04839666 - Hypersensitivity Reactions to Propofol in Children